Precision BioSciences Prices $125 Million Public Offering
at www.tipranks.com (Fri, 6-Nov 7:29 AM)
DTIL Jumps After DSMB Clears PBGENE-DMD to Dose More Patients Following 8-Week Safety Check
Market Chameleon (Thu, 5-Nov 10:28 AM)
DTIL Prices a $125 Million Equity Offering at $7.75 to Fund PBGENE-HBV and PBGENE-DMD R&D
Market Chameleon (Thu, 5-Nov 8:27 AM)
Precision BioSciences announces $125M public offering; shares up
at seekingalpha.com (Thu, 5-Nov 8:54 AM)
Precision BioSciences Reports Positive Clinical Trial Updates
at www.tipranks.com (Thu, 5-Nov 8:08 AM)
